Skip to main content

Advertisement

SpringerLink
Log in

Skin Manifestations of Internal Disease in Older Adults

  • Dermatology and Wound Care (M Reddy, Section Editor)
  • Published:
Current Geriatrics Reports Aims and scope Submit manuscript

Abstract

The skin is the largest and most visible organ in the body and can give diagnostic clues of systemic illness. These clues often become obscured through the normal aging process. The purpose of this review is to give an overview of the normal skin changes seen with aging and then discuss new findings with regards to cutaneous signs of systemic disease in the elderly. We performed a literature search on cutaneous manifestations of internal disease and limited our search to articles published within the last 5 years. We then narrowed down the articles on conditions that primarily affect the adults over the age of 65; conditions commonly seen in the elderly as well as new findings which we felt were of great significance. Ultimately, we hope to update the reader on new cutaneous diagnostic tools of internal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. http://www.senescence.info/aging_theories.html

  2. Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120(4):437–47.

    Article  CAS  PubMed  Google Scholar 

  3. Hjelmborg VJ, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006;119(3):312–21.

    Article  Google Scholar 

  4. Vaziri H, Benchimol S. From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp Gerontol. 1996;31:295–301.

    Article  CAS  PubMed  Google Scholar 

  5. Davis T et al. Prevention of accelerated cell aging in the Werner syndrome. Ann N Y Acad Sci. 2006;1067:243–7.

    Article  CAS  PubMed  Google Scholar 

  6. Manju K, Muralikrishna B, Parnaik VK. Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci. J Cell Sci. 2006;119:2704–14.

    Article  CAS  PubMed  Google Scholar 

  7. De la Fuente M, Hernanz A, Vallejo MC. The immune system in the oxidative stress conditions of aging and hypertension: Favorable effects of antioxidants and physical exercise. Antioxid Redox Signal. 2005;7:1356–66.

    Article  PubMed  Google Scholar 

  8. Sela BA. Dermatological manifestations of smoking. Harefuah. 2002;141(8):736–40.

    CAS  PubMed  Google Scholar 

  9. Wulf HC et al. Skin aging and natural photoprotection. Micron. 2004;35:185–91.

    Article  CAS  PubMed  Google Scholar 

  10. Roskos KV et al. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: The effect of aging on microcirculation. Br J Dermatol. 1990;122:165–71.

    Article  CAS  PubMed  Google Scholar 

  11. Tezuka T et al. Terminal differentiation of facial epidermis of the aged: Immunohistochemical studies. Dermatology. 1994;188:21–4.

    Article  CAS  PubMed  Google Scholar 

  12. Plowden J et al. Innate immunity in aging: Impact on macrophage function. Aging Cell. 2004;3:161–7.

    Article  CAS  PubMed  Google Scholar 

  13. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353–73.

    Article  CAS  PubMed  Google Scholar 

  15. Tsuchida Y. The effect of aging and arteriosclerosis on human skin blood flow. J Dermatol Sci. 1993;5:175–81.

    Article  CAS  PubMed  Google Scholar 

  16. Ryan T. The ageing of the blood supply and the lymphatic drainage of the skin. Micron. 2004;35:161–71.

    Article  CAS  PubMed  Google Scholar 

  17. Gerstein AD et al. Wound healing and aging. Dermatol Clin. 1993;11:749–57.

    CAS  PubMed  Google Scholar 

  18. Longo C, Casari A, Beretti F, Cesinaro A, Pellacani.G. Skin aging: In vivo microscopic assessment of epidermal and dermal shcanges by means of confocal microscopy. Jaad Online October, 2011.

  19. Armstrong BK, Kricker A. Epidemiology of sun exposure and skin cancer. Cancer Surv. 1996;26:133–53.

    CAS  PubMed  Google Scholar 

  20. Matterne U, Apgelbacher CJ, Vogelgsang L, Loerbroks A, Weisshar E. Incindence and determinants of chronic pruritis: a population-based cohort study. Acta Derm Venereol. 2013;93:532–7.

    Article  PubMed  Google Scholar 

  21. Stander S et al. Clinical classification of itch: A position paper of the International Forum for the study of Itch. Acta Derm Venereol. 2007;87(4):291–4.

    Article  PubMed  Google Scholar 

  22. Shelley WB, Arthur RP. The neurohistology and neurophysiology of the itch sensation in man. AMA Arch Derm. 1957;76(3):296–323.

    Article  CAS  PubMed  Google Scholar 

  23. Schmelz M et al. Specific C-receptors for itch in human skin. J Neurosci. 1997;17(20):8003–8.

    CAS  PubMed  Google Scholar 

  24. Berger T, Steinhoff M. Pruritus in elderly patients-eruptions of senescence. Semin Cutaneous Med Surg. 2011;30:113–7.

    Article  CAS  Google Scholar 

  25. Fleicher A. Pruritus in the elderly: managment by senior dermatologists. JAAD. 1993;28:603–9.

    Article  Google Scholar 

  26. Pisoni RL et al. Pruritus in haemodialysis patients: international results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.

    Article  PubMed  Google Scholar 

  27. Teoh YL.et al Pruritus in the elderly and its impact on quality of life. Jaad April 2012 Poster Reference number 5327.

  28. Fett N et al. Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices. JAAD. 2014;70(4):651–8. Patients with chronic pruritus are often extensively worked up for malignancy which drives up health care costs. This paper concludes patient with chronic pruritus without skin findings and no other signs or symptoms of malignancy should not undergo broad screening.

    Article  Google Scholar 

  29. Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther. 2010;23(6):590–6.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Sigurdsson V, Steegmans PH, van Vloten WA. The incidence of erythroderma: a survey among all dermatologists in the Netherlands. J Am Acad Dermatol. 2001;45(5):675–8.

    Article  CAS  PubMed  Google Scholar 

  31. Rym BM et al. Erythroderma in adults: a report of 80 cases. Int J Dermatol. 2005;44(9):731–5.

    Article  PubMed  Google Scholar 

  32. Sigurdsson V et al. Idiopathic erythroderma: a follow-up study of 28 patients. Dermatology. 1997;194(2):98–101.

    Article  CAS  PubMed  Google Scholar 

  33. Shuster S. High-output cardiac failure from skin disease. Lancet. 1963;1(7295):1338–40.

    Article  CAS  PubMed  Google Scholar 

  34. Sehgal VN, Srivastava G. Exfoliative dermatitis. A prospective study of 80 patients. Dermatologica. 1986;173(6):278–84.

    Article  CAS  PubMed  Google Scholar 

  35. Protopsaltis et al. Breast cancer presenting as paraneoplastic erythroderma: An extremelty rare case. Cae Reports in Medicine Vol 2014, Article ID 351065.

  36. Gudi VS et al. Annual incidence and mortality of bullous pemphigoid in the Grampian region of north-east Scotland. Br J Dermatol. 2005;153(2):424.

    Article  CAS  PubMed  Google Scholar 

  37. Cram DL, Fukuyama K. Immunohistochemistry of ultraviolet-induced pemphigus and pemphigoid lesions. Arch Dermatol. 1972;106(6):819.

    Article  CAS  PubMed  Google Scholar 

  38. Jedlickova H et al. Bullous pemphigoid and internal diseases – A case-control study. Eur J Dermatol. 2010;20(1):96.

    PubMed  Google Scholar 

  39. Brick K et al. A population-based study of the association between bullous pemphigoid and neurologic disorder. JAAD. 2014;71(6):1191–7. BP is the most common bullous disease in the elderly so knowing of the association with neulogic disorders can assist the physician in their screening practices.

    Article  Google Scholar 

  40. Stinco G, Codutti R, Scarbolo M, Valent F, Patrone P. A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. Acta Derm Venereol. 2005;85:136–9.

    Article  PubMed  Google Scholar 

  41. Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, et al. Neurological disorders in patients with bullous pemphigoid. Dermatology. 2007;215:187–91.

    Article  PubMed  Google Scholar 

  42. Foureur N, Mignot S, Senet P, Verpillat P, Picard-Dahan C, Crickx B. Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid. Ann Dermatol Venereol. 2006;133:439–43.

    Article  CAS  PubMed  Google Scholar 

  43. Seppanen A, Autio-Hermalinen H, Alafuzoff I, Sarkioja T, Veijola J, Jurskainem T, et al. Collagen XVII is expressed in human CNS neurons. Matrix BIol. 2006;25:185–8.

    Article  PubMed  Google Scholar 

  44. Seppeanen A, Suuronen T, Hofmann SC, Majamaa K, Alafuzoff I. Distribution of collagen XVII in the human brain. Brain Res. 2007;158:50–6.

    Article  Google Scholar 

  45. Curth HO. Skin lesions and internal carcinoma. Cancer of the skin. Biol Diagn Manag. 1976;2:1308–41.

    Google Scholar 

  46. Cohen PR, Kurzrock R. Mucocutaneous paraneoplastic syndromes. Semin Oncol. 1997;24–3:334–59.

    Google Scholar 

  47. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010;85–9:838–54.

    Article  Google Scholar 

  48. Poole S. Fenske, NA. Cutaneous markers of internal malignancy: I. Malignant involvement of the skin and the genodermatoses. JAAD. 1993;28(1):1–13.

    Article  CAS  Google Scholar 

  49. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323(25):1729–35.

    Article  CAS  PubMed  Google Scholar 

  50. Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc. 2004;9(1):29–33.

    Article  PubMed  Google Scholar 

  51. Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol. 1993;129:883–6.

    Article  CAS  PubMed  Google Scholar 

  52. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol. 1997;12:77–96.

    CAS  PubMed  Google Scholar 

  53. Boyce S, Harper J. Paraneoplastic dermatoses. Dermatol Clin. 2002;20(3):523–32.

    Article  PubMed  Google Scholar 

  54. Gissi DB, Bernardi A, D’Andrea M, Montebugnoli L. Paraneoplastic pemphigus presenting with a single oral lesion. BMJ Case Rep 2013; pii: bcr2012007771.

  55. Nousari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med. 1999;340:1406.

    Article  CAS  PubMed  Google Scholar 

  56. Winkler DT, Strnad P, Meier ML, Roten S, Went P, Lyrer P, et al. Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade. J Neurol. 2007;254(11):1601–3.

    Article  CAS  PubMed  Google Scholar 

  57. Chorzelski T, Hashimoto T, Maciejewska B, Amagai M, Anhalt GJ, Jablonska S. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol. 1999;41(3 Pt 1):393–400.

    Article  CAS  PubMed  Google Scholar 

  58. Wang R, Li J, Wang M, Hao H, Chen X, Li R, Zhu X. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis. Br J Dermatol. 2014; doi: 10.1111/bjd.13525 Epub ahead of print This study suggests an association between paraneoplastic pemphigus and myasthenia gravis that has not previously been clearly established. Recognition of this association may be helpful in the recognition and management of paraneoplastic pemphigus.

  59. Joly P, Richard C, Gilbert D, Courville P, et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol. 2000;43:619–26.

    Article  CAS  PubMed  Google Scholar 

  60. Lehman VT, Barrick BJ, Pittelkow MR, Peller PJ, Camilleri MJ, Lehman JS. Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients. Int J Dermatol. 2014 Jul 29. doi: 10.1111/ijd.12603. [Epub ahead of print].

  61. Rodot S, Botcazou V, Lacour JP, et al. Paraneoplastic pemphigus: review of the literature, apropos of a case associated with chronic lymphoid leukemia. Rev Med Interne. 1995;16(12):938–43.

    Article  CAS  PubMed  Google Scholar 

  62. Leger S, Picard D, Ingen-Housz-Oro S, Arnault JP, Aubin F, Carsuzaa F, et al. Prognostic factors of paraneoplastic pemphigus. Arch Derm. 2012;148(10):1165–72.

    Article  PubMed  Google Scholar 

  63. Mutasim DF, Pelc NJ, Anhalt GJ. Paraneoplastic pemphigus. Dermatol Clin. 1993;11(3):473–81.

    CAS  PubMed  Google Scholar 

  64. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. 2014.

  65. Hong MK, Kong J, Namdarian B, Longano A, Grummet J, Hovens CM, et al. Paraneoplastic syndromes in prostate cancer. Nat Rev Urol. 2010;7(12):681–92.

    Article  PubMed  Google Scholar 

  66. Matzkin H, Braf Z. Paraneoplastic syndromes associated with prostatic carcinoma. J Urol. 1987;138:1129–33.

    CAS  PubMed  Google Scholar 

  67. Subramonian K, Sundaram SK, MacDonald Hull SP. Carcinoma of the prostate associated with dermatomyositis. BJU Int. 2000;86:401–2.

    Article  CAS  PubMed  Google Scholar 

  68. Obasi OE, Garg SK. Bazex paraneoplastic acrokeratosis in prostate carcinoma. Br J Dermatol. 1987;117:647–51.

    Article  CAS  PubMed  Google Scholar 

  69. Da Rosa AC, Pinto GM, Bortoluzzi JS, Duquia RP, de Almeida Jr HL. Three simultaneous paraneoplastic manifestations (ichthyosis acquisita, Bazex syndrome, and Leser-Trelat sign) with prostate adenocarcinoma. J Am Acad Dermatol. 2009;61:538–40.

    Article  PubMed  Google Scholar 

  70. Momm F, Pflieger D, Lutterbach J. Paraneoplastic erythroderma in a prostate cancer patient. Strahlenther Onkol. 2002;178:393–5.

    Article  PubMed  Google Scholar 

  71. McCourt C, Feighery C, McIntyre G, Walsh M, Hoey S. Eruptive nevi in prostate cancer: is this a paraneoplastic phenomenon? Int J Dermatol. 2013;52(2):212–3.

    Article  PubMed  Google Scholar 

  72. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. JAAD. 1993;29:228–36.

    Article  CAS  Google Scholar 

  73. Rolz-Cruz G, Kim CC. Tumor invasion of the skin. Dermatol Clin. 2008;26:89–102.

    Article  CAS  PubMed  Google Scholar 

  74. Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96(2):164–7.

    Article  PubMed  Google Scholar 

  75. Wong CY, Helm MA, Helm TN, Zeitouni N. Patterns of skin metastases: a review of 25 years’ experience at a single cancer center. Int J Dermatol. 2014;53(1):56–60. An important component to the early recognition of cutaneous metastasis is an understanding of which primary cancers are most frequently involved. This article provides an update of these frequencies. A better understanding of this will help to guide history, physical examinations, and work-up in patients suspected to have cutaneous metastasis.

    Article  PubMed  Google Scholar 

  76. Blecher K, Friedman A. A biopsy diagnosis? clinical clues and patterns to help distinguish cutaneous metastases: part I of II. J Drugs Dermatol. 2011;10(6):678–82.

    PubMed  Google Scholar 

  77. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004;31(6):419.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Brandon Markus declares that he has no conflict of interest.

Benjamin M. Perry declares that he has no conflict of interest.

William Lear declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Silver Falls Dermatology, 1430 Commercial St., Salem, OR, 97302, USA

    Brandon Markus, Benjamin M. Perry & William Lear

Authors
  1. Brandon Markus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin M. Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William Lear
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brandon Markus.

Additional information

This article is part of the Topical Collection on Dermatology and Wound Care

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Markus, B., Perry, B.M. & Lear, W. Skin Manifestations of Internal Disease in Older Adults. Curr Geri Rep 4, 257–264 (2015). https://doi.org/10.1007/s13670-015-0135-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13670-015-0135-8

Keywords

Search

Navigation